867034-16-0 Usage
Molecular Structure
1H-Pyrrolo[2,3-c]pyridine-2-carboxylic acid, 7-[bis(phenylmethyl)amino]has a complex molecular structure that includes a pyrrolopyridine nucleus with a carboxylic acid group attached at position 2.
Carboxylic Acid Group
The presence of a carboxylic acid group (-COOH) at position 2 contributes to the compound's acidity and potential for forming hydrogen bonds, which can affect its solubility and reactivity.
Pyrrolopyridine Nucleus
The core structure of the compound consists of a fusion between a pyrrole and a pyridine ring, which may contribute to its potential applications in medicinal chemistry due to the diverse biological activities associated with such ring systems.
Pharmaceutical Relevance
The structural features of 1H-Pyrrolo[2,3-c]pyridine-2-carboxylic acid, 7-[bis(phenylmethyl)amino]suggest that it may have potential applications in the pharmaceutical industry, possibly as a drug candidate or a building block for the synthesis of more complex molecules.
Further Research
Due to its unique structure and potential applications, further research into the properties and potential uses of 1H-Pyrrolo[2,3-c]pyridine-2-carboxylic acid, 7-[bis(phenylmethyl)amino]may be warranted to explore its full potential in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 867034-16-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,7,0,3 and 4 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 867034-16:
(8*8)+(7*6)+(6*7)+(5*0)+(4*3)+(3*4)+(2*1)+(1*6)=180
180 % 10 = 0
So 867034-16-0 is a valid CAS Registry Number.
867034-16-0Relevant academic research and scientific papers
6-AZAINDOLE COMPOUND
-
, (2008/06/13)
A compound represented by the formula (I) wherein R1, R2, R3 and R6 are the same or different and each is a hydrogen atom or a substituent; one of R4 and R5 is a hydrogen atom and the other is a group represented by the formula: -C(=X)-R7 wherein X is N-O-R8 or N-NH-R9 wherein R8 and R9 are the same or different and each is a hydrogen atom or a group bonded via a carbon atom; and R7 is a hydrogen atom or a substituent, and the like and a salt thereof have a superior IκB kinase inhibitory activity, and useful as pharmaceutical agents such as agents for preventing or treating diabetes and the like.
